GlassScriptPhysician profile
Ibrahim Yaghnam
NPI 1780175679
$8,478.11
in general payments reported to CMS, 2019-2025
4 companies · $2,192 in 2025
The $2,192 reported for 2025 was more than what 81% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $99.95 · 2022: $99.00 · 2023: $3,183 · 2024: $2,904 · 2025: $2,192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,011 · Food and Beverage: $1,392 · Grant: $800 · Education: $76.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,010.76 |
| Food and Beverage | $1,392.40 |
| Grant | $800.00 |
| Education | $76.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,554.69 | 2024-2025 | Axios, Overstitch Endoscopic Suturing System |
| Olympus Corporation of The Americas | $2,751.93 | 2023-2024 | Disposable Distal Attachment, Single Use Electrosurgical Knife Kd-655, Olympus |
| Cook Incorporated | $800.00 | 2023 | |
| Janssen Biotech, INC. | $371.49 | 2021-2023 | Stelara, Tremfya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ibrahim Yaghnam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.